Project Grant R01CA301464
Award Date 9/19/25
Completion Date 8/31/29
Dollars Obligated $3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
- The National Cancer Institute awarded a $1,542,555 Project Grant to Sloan-Kettering Institute For Cancer Research under the Cancer Treatment Research program (CFDA 93.395). The grant will fund research from December 2022 through November 2027 to develop more effective treatments for localized bladder cancer. Specifically, the grantee will conduct genomic analyses of bladder cancer patient cohorts to validate DNA damage response mutations as predictors of sensitivity to bacillus Calmette-Guérin...
- The University of Southern California (USC) was awarded a $426,828 Project Grant from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop DNA methylation markers for the early detection and monitoring of tumor burden in bladder cancer. The award, which runs from August 2025 to July 2027, will support USC's research to identify bladder cancer-specific DNA methylation changes that can be detected non-invasively in urine sediments. This aims to...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $297,074 to the University of California, Davis to integrate fluorescence lifetime imaging (FLIM) technology into standard colonoscopy procedures. The goal is to enhance the real-time detection and characterization of colorectal lesions, addressing limitations of current colonoscopy techniques. Key research activities include: Building a comprehensive database of...
- This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,491 to Northridge Tri-Modality Imaging Inc. to upgrade their gantry-based imaging system to incorporate bioluminescence tomography (BLT) capabilities. The upgraded system will enable 3D whole-body fluorescent, bioluminescent, and anatomical X-ray imaging of small animal cancer models, providing a comprehensive multimodal imaging...
- This Project Grant award of $684,877 from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) will support a multi-scale analysis of the Bacillus Calmette-Guerin (BCG) resistant tumor microenvironment in non-muscle invasive bladder cancer (NMIBC). The study aims to generate a comprehensive molecular atlas of the NMIBC tumor microenvironment, using matched single-nucleus RNA and ATAC sequencing, as well as spatial sequencing, across 36 samples....
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $670,147 to Vanderbilt University Medical Center to conduct research aimed at improving the clinical sensitivity of circulating tumor DNA (ctDNA) liquid biopsies. The research program has three key objectives: 1) Elucidating the role of the RNA binding protein SAM68 in mediating cell-free DNA (cfDNA) release, 2) Pharmacologically optimizing cfDNA release and stability to...
- This National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research) Project Grant award of $683,089 to the Sloan-Kettering Institute for Cancer Research supports the development of an improved, interpretable deep learning algorithm called DeepLIIF for more reproducible and accurate PD-L1 immunohistochemistry (IHC) biomarker quantification. The goal is to leverage virtual multiplex immunofluorescence (MPIF) restaining and large, diverse datasets across lung and bladder cancers to...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,990 to Scorpido Photonics aims to develop a prototype endoscope-based diagnostic system for rapid, non-invasive detection of microscopic tumors. The project integrates plasmonic nanobubble sensors into a medical device platform and standard endoscope to enable instant, optical detection of cancerous tissues during lung cancer diagnostic procedures. The key product is a...
- This federal Project Grant award of $930,500 from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research by the University of Arizona to understand the biological mechanisms underlying loss of the Y chromosome (LOY) in cancer, with a focus on bladder cancer. The key products and services to be delivered under this multi-year award (Sep 2025 - Aug 2032) include: Identifying new genes and biomarkers related to bladder cancer growth, metastasis, and patient outcomes...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $2,491,138 to Oregon Health & Science University (OHSU) to develop a fluorescence-guided nerve-sparing technique for colorectal cancer surgery. The project aims to enable real-time visualization of nerves during surgery using a novel near-infrared fluorescent contrast agent, with the goal of improving surgical outcomes and reducing post-operative morbidity such as...